These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6742874)

  • 1. Intravenous indomethacin for patent ductus arteriosus.
    Smith IJ; Goss I; Congdon PJ
    Arch Dis Child; 1984 Jun; 59(6):537-41. PubMed ID: 6742874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus.
    Achanti B; Yeh TF; Pildes RS
    Clin Invest Med; 1986 Nov; 9(4):250-3. PubMed ID: 3802612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum indomethacin concentrations after intravenous administration to preterm infants with patent ductus arteriosus.
    Petersen S; Christensen NC; Møller Jensen K; Ryssing E
    Acta Paediatr Scand; 1981 Sep; 70(5):729-33. PubMed ID: 7324922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Dumas de la Roque E; Fayon M; Babre F; Demarquez JL; Pedespan L
    Biol Neonate; 2002; 81(2):91-4. PubMed ID: 11844876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
    Heo MJ; Lee OS; Lim SC
    Arch Pharm Res; 2012 Sep; 35(9):1673-83. PubMed ID: 23054725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin dosing strategy and neonatal patent ductus arteriosus closure.
    Rathi P; Messina C; Mintzer JP
    J Neonatal Perinatal Med; 2019; 12(4):411-417. PubMed ID: 31561393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin and the preterm infant with a patent ductus arteriosus: relationship between plasma concentration and ductus closure.
    Friedman CA; Parks BR; Rawson JE; Serwer GA; Anderson PA
    Dev Pharmacol Ther; 1982; 4(1-2):37-46. PubMed ID: 7117089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orogastric and intravenous indomethacin administration to very premature neonates with patent ductus arteriosus: population pharmacokinetics, absolute bioavailability, and treatment outcome.
    Al Za'abi M; Donovan T; Tudehope D; Woodgate P; Collie LA; Charles B
    Ther Drug Monit; 2007 Dec; 29(6):807-14. PubMed ID: 18043480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
    Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
    An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of intravenous indomethacin in neonates with symptomatic patent ductus arteriosus.
    Wiest DB; Pinson JB; Gal PS; Brundage RC; Schall S; Ransom JL; Weaver RL; Purohit D; Brown Y
    Clin Pharmacol Ther; 1991 May; 49(5):550-7. PubMed ID: 2029829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin.
    Coombs RC; Morgan ME; Durbin GM; Booth IW; McNeish AS
    Arch Dis Child; 1990 Oct; 65(10 Spec No):1067-71. PubMed ID: 2241229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants.
    Lemmers PM; Toet MC; van Bel F
    Pediatrics; 2008 Jan; 121(1):142-7. PubMed ID: 18166568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin for patent ductus arteriosus closure. Application of serum concentrations and pharmacodynamics to improve response.
    Gal P; Ransom JL; Schall S; Weaver RL; Bird A; Brown Y
    J Perinatol; 1990 Mar; 10(1):20-6. PubMed ID: 2313390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.
    Mrongovius R; Imbeck H; Wille L; Müller H; Seyberth HW
    Eur J Pediatr; 1982 Mar; 138(2):151-3. PubMed ID: 7094936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.
    Kääpä P; Lanning P; Koivisto M
    Acta Paediatr Scand; 1983 Mar; 72(2):179-84. PubMed ID: 6340412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.
    Lewis IG; Harvey DP; Maxwell GM
    Aust Paediatr J; 1985 Aug; 21(3):181-3. PubMed ID: 4062716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.